185 related articles for article (PubMed ID: 8090821)
1. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41.
Conti LH; Costello DG; Martin LA; White MF; Abreu ME
Pharmacol Biochem Behav; 1994 Jun; 48(2):497-503. PubMed ID: 8090821
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
Britton KT; Lee G; Vale W; Rivier J; Koob GF
Brain Res; 1986 Mar; 369(1-2):303-6. PubMed ID: 3008937
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
Pelleymounter MA; Joppa M; Ling N; Foster AC
J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
[TBL] [Abstract][Full Text] [Related]
4. A role for corticotropin-releasing factor in repeated cold stress-induced anxiety-like behavior during forced swimming and elevated plus-maze tests in mice.
Nishikawa H; Hata T; Itoh E; Funakami Y
Biol Pharm Bull; 2004 Mar; 27(3):352-6. PubMed ID: 14993801
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
[TBL] [Abstract][Full Text] [Related]
6. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice.
Berridge CW; Dunn AJ
Horm Behav; 1987 Sep; 21(3):393-401. PubMed ID: 3499373
[TBL] [Abstract][Full Text] [Related]
7. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
Stenzel-Poore MP; Heinrichs SC; Rivest S; Koob GF; Vale WW
J Neurosci; 1994 May; 14(5 Pt 1):2579-84. PubMed ID: 8182429
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
Curtis AL; Grigoriadis DE; Page ME; Rivier J; Valentino RJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):359-65. PubMed ID: 8301577
[TBL] [Abstract][Full Text] [Related]
9. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats.
Sarnyai Z; Höhn J; Szabó G; Penke B
Life Sci; 1992; 51(26):2019-24. PubMed ID: 1335535
[TBL] [Abstract][Full Text] [Related]
10. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
Fisher L; Rivier C; Rivier J; Brown M
Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
[TBL] [Abstract][Full Text] [Related]
11. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice.
Bhutada P; Mundhada Y; Bansod K; Ubgade A; Quazi M; Umathe S; Mundhada D
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):955-60. PubMed ID: 20447436
[TBL] [Abstract][Full Text] [Related]
12. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
Korte SM; Korte-Bouws GA; Bohus B; Koob GF
Physiol Behav; 1994 Jul; 56(1):115-20. PubMed ID: 8084889
[TBL] [Abstract][Full Text] [Related]
13. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
Diamant M; de Wied D
Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
[TBL] [Abstract][Full Text] [Related]
14. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.
Rassnick S; Heinrichs SC; Britton KT; Koob GF
Brain Res; 1993 Mar; 605(1):25-32. PubMed ID: 8467387
[TBL] [Abstract][Full Text] [Related]
15. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor.
Dunn AJ; Antoon M; Chapman Y
Brain Res Bull; 1991 Apr; 26(4):539-42. PubMed ID: 1868353
[TBL] [Abstract][Full Text] [Related]
16. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
Salak-Johnson JL; Anderson DL; McGlone JJ
Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
Britton KT; Akwa Y; Spina MG; Koob GF
Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
Griebel G; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.
Takahashi LK; Ho SP; Livanov V; Graciani N; Arneric SP
Brain Res; 2001 Jun; 902(2):135-42. PubMed ID: 11384606
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor and schedule-induced polydipsia.
Cole BJ; Koob GF
Pharmacol Biochem Behav; 1994 Mar; 47(3):393-8. PubMed ID: 8208756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
